Medpace Holdings, Inc. MEDP Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medpace Holdings, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medpace Holdings, Inc.'s accrued expenses?
- Medpace Holdings, Inc. (MEDP) reported accrued expenses of $61.6M in Q1 2026.
- How has Medpace Holdings, Inc.'s accrued expenses changed year-over-year?
- Medpace Holdings, Inc.'s accrued expenses increased by 15.8% year-over-year, from $53.19M to $61.6M.
- What is the long-term trend for Medpace Holdings, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s accrued expenses has grown at a 27.8% compound annual growth rate (CAGR), from $23.53M to $80.14M.
- What does accrued expenses mean?
- Expenses that have been incurred but not yet paid or invoiced.
- How do you interpret accrued expenses?
- Significant fluctuations may indicate changes in operational scale or shifts in the timing of variable compensation and project-related costs.
- How does accrued expenses compare across companies?
- Accruals are standard across the CRO sector due to the project-based nature of clinical trial expenses.